The use of novel drugs can effectively improve response, delay relapse and enhance overall survival in multiple myeloma patients with renal impairment.

por Katarina Uttervall, Adil D Duru, Johan Lund, Johan Liwing, Gösta Gahrton, Erik Holmberg, Johan Aschan, Evren Alici, Hareth Nahi
Publicado 2014